- Home
- HCM vs IDYA Comparison
HCM vs IDYA Comparison
Compare HCM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- IDYA
- Stock Information
- Founded
- HCM 2000
- IDYA 2015
- Country
- HCM Hong Kong
- IDYA United States
- Employees
- HCM N/A
- IDYA N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- HCM Health Care
- IDYA Health Care
- Exchange
- HCM Nasdaq
- IDYA Nasdaq
- Market Cap
- HCM 2.3B
- IDYA 2.0B
- IPO Year
- HCM N/A
- IDYA 2019
- Fundamental
- Price
- HCM $13.52
- IDYA $24.11
- Analyst Decision
- HCM Hold
- IDYA Strong Buy
- Analyst Count
- HCM 1
- IDYA 13
- Target Price
- HCM $19.00
- IDYA $53.67
- AVG Volume (30 Days)
- HCM 85.0K
- IDYA 825.9K
- Earning Date
- HCM 02-26-2025
- IDYA 02-18-2025
- Dividend Yield
- HCM N/A
- IDYA N/A
- EPS Growth
- HCM N/A
- IDYA N/A
- EPS
- HCM N/A
- IDYA N/A
- Revenue
- HCM $610,806,000.00
- IDYA $3,922,000.00
- Revenue This Year
- HCM N/A
- IDYA N/A
- Revenue Next Year
- HCM $18.76
- IDYA $273.42
- P/E Ratio
- HCM N/A
- IDYA N/A
- Revenue Growth
- HCM N/A
- IDYA N/A
- 52 Week Low
- HCM $13.00
- IDYA $22.10
- 52 Week High
- HCM $21.92
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- HCM 40.71
- IDYA 48.30
- Support Level
- HCM $13.10
- IDYA $23.29
- Resistance Level
- HCM $13.92
- IDYA $24.97
- Average True Range (ATR)
- HCM 0.38
- IDYA 1.05
- MACD
- HCM 0.02
- IDYA 0.21
- Stochastic Oscillator
- HCM 37.96
- IDYA 70.03
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.